We are committed to serving the needs of emerging and mid-tier biopharmaceutical and medical device firms, as well as academic researchers, research networks, and foundations
Morrisville, N.C. (PRWEB) September 17, 2008
Clinipace, a growing on-demand clinical research software company, today announced that it has been awarded ten new projects worth, in aggregate, more than $1 million. These projects include early-stage clinical trials, registries, and investigator-initiated research grant management for mid-tier life sciences firms, research networks, and foundations.
After a successful capital infusion from Hatteras Venture Partners (http://www.hatterasvp.com) in late 2007 and increasing demand for affordable software within the mid-market, Clinipace has expanded its staff by over 50 percent, primarily within its sales and services teams. In recent months, Clinipace has signed five new customers, including Inspire Pharmaceuticals, VaxInnate, SHS International, and the Crohn's & Colitis Foundation of America. It was also awarded five additional software projects from existing customers.
"We are committed to serving the needs of emerging and mid-tier biopharmaceutical and medical device firms, as well as academic researchers, research networks, and foundations," said Jeff Williams, Chief Executive Officer at Clinipace. "These organizations have been largely ignored by established eClinical software vendors because of their size and budget constraints. We are seeing tremendous interest and demand for our solutions, and our investment in operational excellence enables us to deliver it for 30-50 percent less than the cost of comparable systems. In this way, we are democratizing eClinical software, ensuring that every organization has access to an easy-to-use and comprehensive system that spans the clinical trial life cycle and empowers all constituents," Williams explains.
Clinipace is a clinical research software company providing a single, integrated data capture and study management platform for clinical trials, investigator-initiated research grant management, and registries conducted by biopharmaceutical and medical device companies and Academic Medical Centers (AMCs). Our TEMPO platform is delivered via a web-based, on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms, reducing project efforts and costs from startup to conclusion, and empowering project stakeholders to make informed real-time decisions regarding their research. For more information on Clinipace, please visit: http://www.clinipace.com